Lyra Therapeutics (LYRA) Misses Q1 EPS by 1c

Lyra Therapeutics (NASDAQ: LYRA) reported Q1 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Lyra Therapeutics (LYRA) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• SK Hynix (SKHY) call put ratio 1.4 calls to 1 put as share price up 3.8%
• Oracle (ORCL) call put ratio 4 calls to 1 put with a focus on September 165 calls into quarter results